CRL · Charles River Laboratories International Inc
United States · RS rating 97 · As of 2026-10-14
| Price | 302.00 USD |
|---|---|
| 1-day change | +1.0% |
| RS rating (overall / 1M / 3M / 12M) | 97 / 94 / 94 / 93 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 45 / 56 / 36 |
| Industry group (rank) | Medical-Research Eqp/Svc (31) |
| EPS growth Q/Q | -610.9% |
| Sales growth Q/Q | -1.1% |
| Distance from 52-week high | +2.8% |
| Market cap (USD) | $8.3B |